Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,125 shares at $152.24 ($325K) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Scheduled sale ($325k) by EVP, CFO & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.24 | 925 | $141K | 43.3% |
| 2 | $153.30 | 1,100 | $169K | 51.9% |
| 3 | $154.13 | 100 | $15K | 4.7% |
| Total | $152.88 avg | 2,125 | $325K | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |